ArticleFrontiers in drug safety and regulation2025

A real-world disproportionality analysis of roflumilast using the US food and drug administration adverse event reporting system data.

Baiqing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.